ARTICLE | Clinical News
Caprelsa regulatory update
December 9, 2016 12:04 AM UTC
EMA’s CHMP recommended expanding the label of Caprelsa vandetanib from Sanofi to treat aggressive and symptomatic medullary thyroid cancer (MTC) in patients with unresectable locally advanced or meta...